Deep Dive
Event-Driven vs Technical Trading
Technical traders read charts. Event-driven traders read the calendar. Both approaches work — but price-only backtests systematically miss the biggest market moves. Here’s why.
Two ways to see the market
Uses price, volume, and indicators (RSI, MACD, moving averages) to predict future moves. The belief: all information is already reflected in price.
“AAPL crossed above its 50-day MA on rising volume — buy.”
Trades around specific catalysts: earnings reports, FDA decisions, Fed meetings, insider filings, product launches. The belief: events create predictable patterns.
“AAPL reports earnings in 5 days with whisper numbers above consensus — buy.”
The data tells a clear story
Academic research from the Journal of Financial Economics consistently shows that 60–80% of annual stock returns cluster around a handful of event days — earnings, guidance changes, analyst upgrades, and macro announcements. A technical system that treats every day the same misses this concentration.
“On any given earnings day, TSLA moves more than it does in the other 60 trading days of that quarter combined.”
Why pure technical analysis underperforms
Moving average crossovers, RSI signals, and Bollinger Band squeezes were powerful when few people used them. Today, every brokerage app shows them. The alpha from pure technicals has been arbitraged away for most liquid stocks.
Worse, technical signals break down around events. An RSI oversold reading the day before earnings means nothing — the stock could gap 20% in either direction regardless of what the indicator says.
The hybrid approach
The best-performing strategies combine both. Use events to determine when and what to trade. Use technicals to determine how to enter.
- Catalyst filter — Only look at stocks with upcoming earnings, FDA dates, or insider activity
- Technical confirmation — Among those, enter only if momentum is positive (20-day ROC > 0)
- Event-aware exits — Take profit after the event reaction, not on arbitrary price targets
Real example: MRNA and FDA catalysts
“Biotech stocks rally into FDA approval dates”
Simulated backtest. Past performance ≠ future results.
How AlgoThesis combines both approaches
When you type a thesis, AlgoThesis automatically layers catalyst awareness on top of technical signals. It generates strategies that know when earnings are coming, when FDA decisions are scheduled, and when Fed meetings could move your positions. You get the precision of technicals with the timing edge of event-driven trading.
Combine events and technicals in one algo
AlgoThesis builds catalyst-aware strategies from plain English.
Try AlgoThesis Free →